Related references
Note: Only part of the references are listed.Thyroid hormone-responsive SPOT 14 homolog promotes hepatic lipogenesis, and its expression is regulated by Liver X receptor through a sterol regulatory element-binding protein 1c-dependent mechanism in mice
Jing Wu et al.
HEPATOLOGY (2013)
Oxysterol generation and liver X receptor-dependent reverse cholesterol transport: Not all roads lead to Rome
Parveer S. Pannu et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
Liver X Receptors, Atherosclerosis and Inflammation
Daryn R. Michael et al.
CURRENT ATHEROSCLEROSIS REPORTS (2012)
The liver X receptor modulator 22(S)-hydroxycholesterol exerts cell-type specific effects on lipid and glucose metabolism
Nina Pettersen Hessvik et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2012)
Central diabetes insipidus associated with impaired renal aquaporin-1 expression in mice lacking liver X receptor β
Chiara Gabbi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Liver X receptor biology and pharmacology: new pathways, challenges and opportunities
Tomas Jakobsson et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
Hormonal and nutritional regulation of SCD1 gene expression
Daniel Mauvoisin et al.
BIOCHIMIE (2011)
Liver X Receptors A Potential Therapeutic Target for Modulating the Atherosclerotic Process
Neil Parikh et al.
CARDIOLOGY IN REVIEW (2010)
Stearoyl-coenzyme A desaturase 1 inhibition and the metabolic syndrome: considerations for future drug discovery
J. Mark Brown et al.
CURRENT OPINION IN LIPIDOLOGY (2010)
Liver X receptor in cholesterol metabolism
Chunyan Zhao et al.
JOURNAL OF ENDOCRINOLOGY (2010)
Liver X receptor modulators: Effects on lipid metabolism and potential use in the treatment of atherosclerosis
C. Fievet et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Liver X Receptors (LXR) as Therapeutic Targets in Dyslipidemia
Jerzy Beltowski
CARDIOVASCULAR THERAPEUTICS (2008)
Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis
Makoto Miyazaki et al.
CELL METABOLISM (2007)
Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistance
Roger Gutierrez-Juarez et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Liver X receptor agonist TO-901317 upregulates SCD1 expression in renal proximal straight tubule
YH Zhang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2006)
Stearoyl-coenzyme A desaturase 1 deficiency protects against hypertriglyceridemia and increases plasma high-density lipoprotein cholesterol induced by liver X receptor activation
Kiki Chu et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1
GQ Jiang et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
The LXR ligand T0901317 induces severe lipogenesis in the db/db diabetic mouse
JW Chisholm et al.
JOURNAL OF LIPID RESEARCH (2003)
Stearoyl-CoA desaturase 1 deficiency elevates insulin-signaling components and down-regulates protein-tyrosine phosphatase 1B in muscle
SM Rahman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Sterol-regulatory element-binding protein (SREBP)-2 contributes to polygenic hypercholesterolaemia
AR Miserez et al.
ATHEROSCLEROSIS (2002)
LXRα is the dominant regulator of CYP7A1 transcription
S Gupta et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors
SB Joseph et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Cloning and characterization of the human stearoyl-CoA desaturase gene promoter:: Transcriptional activation by sterol regulatory element binding protein and repression by polyunsaturated fatty acids and cholesterol
H Bené et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Share Paper
